Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA; International Nosocomial Infection Control Consortium, Miami, FL, USA.
Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Int J Infect Dis. 2022 May;118:83-88. doi: 10.1016/j.ijid.2022.02.041. Epub 2022 Feb 24.
This study examines the impact of the COVID-19 pandemic on health care-associated infection (HAI) incidence in low- and middle-income countries (LMICs).
Patients from 7 LMICs were followed up during hospital intensive care unit (ICU) stays from January 2019 to May 2020. HAI rates were calculated using the International Nosocomial Infection Control Consortium (INICC) Surveillance Online System applying the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC-NHSN) criteria. Pre-COVID-19 rates for 2019 were compared with COVID-19 era rates for 2020 for central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), mortality, and length of stay (LOS).
A total of 7,775 patients were followed up for 49,506 bed days. The 2019 to 2020 rate comparisons were 2.54 and 4.73 CLABSIs per 1,000 central line days (risk ratio [RR] = 1.85, p = .0006), 9.71 and 12.58 VAEs per 1,000 mechanical ventilator days (RR = 1.29, p = .10), and 1.64 and 1.43 CAUTIs per 1,000 urinary catheter days (RR = 1.14; p = .69). Mortality rates were 15.2% and 23.2% for 2019 and 2020 (RR = 1.42; p < .0001), respectively. Mean LOS for 2019 and 2020 were 6.02 and 7.54 days (RR = 1.21, p < .0001), respectively.
This study documents an increase in HAI rates in 7 LMICs during the first 5 months of the COVID-19 pandemic and highlights the need to reprioritize and return to conventional infection prevention practices.
本研究考察了 COVID-19 大流行对中低收入国家(LMICs)医疗相关感染(HAI)发病率的影响。
本研究对 7 个 LMICs 的患者在 2019 年 1 月至 2020 年 5 月期间的 ICU 住院期间进行了随访。使用国际医院感染控制联盟(INICC)监测在线系统,根据疾病控制和预防中心的国家医疗保健安全网络(CDC-NHSN)标准计算 HAI 发生率。比较了 2019 年的 COVID-19 前发生率与 2020 年 COVID-19 时代的中心静脉导管相关血流感染(CLABSI)、导管相关尿路感染(CAUTI)、呼吸机相关事件(VAE)、死亡率和住院时间(LOS)。
共随访了 7775 例患者,共 49506 个床位日。2019 年至 2020 年的率比较为:每 1000 个中心静脉导管日的 2.54 例和 4.73 例 CLABSI(风险比[RR]为 1.85,p = 0.0006)、每 1000 个机械通气日的 9.71 例和 12.58 例 VAE(RR 为 1.29,p = 0.10)以及每 1000 个导尿管日的 1.64 例和 1.43 例 CAUTI(RR 为 1.14,p = 0.69)。2019 年和 2020 年的死亡率分别为 15.2%和 23.2%(RR 为 1.42,p < 0.0001)。2019 年和 2020 年的平均 LOS 分别为 6.02 天和 7.54 天(RR 为 1.21,p < 0.0001)。
本研究记录了 7 个 LMICs 在 COVID-19 大流行的前 5 个月 HAI 发生率的增加,并强调需要重新优先考虑并恢复常规感染预防措施。